320 related articles for article (PubMed ID: 21493336)
1. Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells.
Furusawa J; Zhang H; Vural E; Stone A; Fukuda S; Oridate N; Fang H; Ye Y; Suen JY; Fan CY
Otolaryngol Head Neck Surg; 2011 Jun; 144(6):900-9. PubMed ID: 21493336
[TBL] [Abstract][Full Text] [Related]
2. CD44 as a stem cell marker in head and neck squamous cell carcinoma.
Faber A; Barth C; Hörmann K; Kassner S; Schultz JD; Sommer U; Stern-Straeter J; Thorn C; Goessler UR
Oncol Rep; 2011 Aug; 26(2):321-6. PubMed ID: 21617876
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
[TBL] [Abstract][Full Text] [Related]
5. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH
Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915
[TBL] [Abstract][Full Text] [Related]
6. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
7. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
[TBL] [Abstract][Full Text] [Related]
8. SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma.
Khammanivong A; Gopalakrishnan R; Dickerson EB
Mol Cancer; 2014 Dec; 13():260. PubMed ID: 25471937
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
[TBL] [Abstract][Full Text] [Related]
10. Metastatic potential of cancer stem cells in head and neck squamous cell carcinoma.
Davis SJ; Divi V; Owen JH; Bradford CR; Carey TE; Papagerakis S; Prince ME
Arch Otolaryngol Head Neck Surg; 2010 Dec; 136(12):1260-6. PubMed ID: 21173377
[TBL] [Abstract][Full Text] [Related]
11. Immunoregulatory properties of CD44+ cancer stem-like cells in squamous cell carcinoma of the head and neck.
Chikamatsu K; Takahashi G; Sakakura K; Ferrone S; Masuyama K
Head Neck; 2011 Feb; 33(2):208-15. PubMed ID: 20848440
[TBL] [Abstract][Full Text] [Related]
12. Isolation and genomic characterization of stem cells in head and neck cancer.
Wilson GD; Marples B; Galoforo S; Geddes TJ; Thibodeau BJ; Grénman R; Akervall J
Head Neck; 2013 Nov; 35(11):1573-82. PubMed ID: 23108794
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
14. Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells.
Chikamatsu K; Ishii H; Takahashi G; Okamoto A; Moriyama M; Sakakura K; Masuyama K
Head Neck; 2012 Mar; 34(3):336-43. PubMed ID: 21472882
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma.
Bourguignon LY; Wong G; Shiina M
J Biol Chem; 2016 May; 291(20):10571-85. PubMed ID: 27002147
[TBL] [Abstract][Full Text] [Related]
16. A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment.
La Fleur L; Johansson AC; Roberg K
PLoS One; 2012; 7(9):e44071. PubMed ID: 23049743
[TBL] [Abstract][Full Text] [Related]
17. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.
Subramanian C; Kovatch KJ; Sim MW; Wang G; Prince ME; Carey TE; Davis R; Blagg BSJ; Cohen MS
Neoplasia; 2017 Dec; 19(12):1003-1011. PubMed ID: 29121598
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.
Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S
Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.
Bae WJ; Koo BS; Lee SH; Kim JM; Rho YS; Lim JY; Moon JH; Cho JH; Lim YC
Br J Cancer; 2017 Dec; 117(12):1810-1818. PubMed ID: 29096401
[TBL] [Abstract][Full Text] [Related]
20. Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status.
Vlashi E; Chen AM; Boyrie S; Yu G; Nguyen A; Brower PA; Hess CB; Pajonk F
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1198-206. PubMed ID: 27026319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
